Potential dosing errors using portable prothrombin time monitoring devices

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 5, 2003, Pages 479-483

  Loebstein, Ronen ^a   Kurnik, Daniel ^a   Lubetsky, Aharon ^a   Ezra, David ^a   Halkin, Hillel ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Accuracy; Clinical agreement; Portable prothrombin time monitors

Indexed keywords

PROTHROMBIN; WARFARIN;

ANTICOAGULATION; ARTICLE; DEVICE; DRUG DOSE REGIMEN; ERROR; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; PROTHROMBIN TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION ERRORS; MIDDLE AGED; PROTHROMBIN TIME; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; WARFARIN;

EID: 0042626436     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200307000-00008     Document Type: Article

References (12)

1. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D. Oral anticoagulants: mechanisms of action, clinical effectiveness and optimal therapeutic range. Chest 2001; 119:8S-21S.
2. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153:1441-1447.
3. Gosselin R, Owings JT, White RH, Hutchinson R, Branch J, Mahackian K, et al. A comparison of point of care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 2000; 83:698-703.
4. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992; 152:589-592.
5. Tripoldi A, Arbini AA, Charangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalization ratio? Thromb Haemost 1993; 70:921-929.
6. Van der Besselaar. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000; 84:410-412.
7. Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable international normalization ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92:11-17.
8. Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000; 83:661-665.
9. Ansell J, Holden A, Knapic N. Patient self-management of oral anticoagulant guided by capillary (fingerstick) whole blood prothrombin time. Arch Intern Med 1989; 149:2509-2511.
10. Woodhams BJ, Klein N, Harz D, Rose M, Ruiz JA. A study of the variability seen in the international normalized ratio obtained using different sensitivity thromboplastin reagents on different instrument types. Blood Coagul Fibrinolysis 1999; 10:423-427.
11. Poller L, Keown M, Chauhan N, Shiach C, Van den Besselaar AMHP, Tripodi A, Jespersen J. European Concerted Action on Anticoagulation (ECAA): International normalized ratio variability of Coaguchek and TAS point of care testing whole blood prothrombin time monitors. Thromb Haemost 2002; 88:992-995.
12. Testa S, Morstabilini G, Fattorini A, Galli L, Denti N, D'Angelo A. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment. Haematologica 2002; 87:1265-1273.